Skip to main navigation Skip to main content
The University of Southampton
Southampton Clinical Trials Unit

Completed Trials Portfolio

Anti-CD66 Logo

Anti-CD66

Using Targeted Radiotherapy delivered by a Radio-labelled Anti-CD66 Monoclonal Antibody with high dose melphalan compared to melphalan alone, prior to Autologous Stem Cell Transplantation for Multiple Myeloma.

ARGO logo

ARGO

A phase II Study of Atezolizumab with Rituximab, Gemcitabine and Oxaliplatin in patients with relapsed or refractory Diffuse Large B-Cell Lymphoma who are not candidates for High Dose Therapy

ATAFUTI Logo

ATAFUTI

Alternative Treatments of Adult Female Urinary Tract Infection: a double blind, placebo controlled, factorial randomised trial of Uva ursi and open pragmatic trial of ibuprofen.

BioStent Logo

BioStent

Biodegradable oesophageal stents plus radiotherapy in carcinoma of the oesophagus.

BREATHE Logo

BREATHE

A controlled study of the effectiveness of breathing retraining exercises taught by a physiotherapist by either instructional DVD or by face-to-face sessions in the management of asthma in adults.

COAST LOGO

COAST

A placebo controlled study to gather initial information on whether aspirin reduces hearing loss/ototoxicity for patients receiving cisplatin chemotherapy.

CONTRACT Logo

CONTRACT

CONservative TReatment of Appendicitis in Children – a randomised controlled Trial (feasibility)

COPPI Logo

COPPI

A multicentre randomised controlled trial comparing the efficacy of a specialist and a generic parenting programme for the treatment of preschool ADHD.

EORTC 40983 Logo

EORTC 40983

Pre and Post-operative chemotherapy with oxaliplatin 5FU/LV V surgery alone if resectable liver metastases from colorectal origin—Phase III study

EPOC B Logo

EPOC B

An exploratory study to investigate the optimal scheduling of chemotherapy in patients with operable colorectal liver metastases.

FACS Logo

FACS

A randomised controlled trial to assess the cost-effectiveness of intensive versus no scheduled follow-up in patients who have undergone resection for colorectal cancer with curative intent.

FORECAST Logo

FORECAST

Fractional Flow Reserve Derived from Computed Tomography Coronary Angiography in the Assessment and Management of Stable Chest Pain.

Gem-TIP Logo

Gem-TIP

Phase I/II multicentre trial of salvage chemotherapy with Gem-TIP for relapsed germ cell cancer.

HATRIC Logo

HATRIC

Herbal Alternative Treatment (Pelargonium) for lower Respiratory tract Infections with Cough in adults

HipOP Logo

Hip 'OP

A study to assess the effect of timing of surgical intervention on the occurrence of Avascular Necrosis in children with Developmental Dysplasia of the Hip - Early Treatment versus Intentionally Delayed Treatment.

ICE Logo

ICE

A Phase II trial of the addition of Ipilimumab to Carboplatin and Etoposide Chemotherapy for the first line treatment of Extensive Stage Small Cell Lung Cancer

IELSG19 Logo

IELSG-19

Multicenter randomised trial of chlorambucil versus chlorambucil plux rituximab versus rituximab alone in extranodal marginal zone B-Cell lymphoma of mucosa associated lymphoid tissue (MALT lymphoma).

IELSG-26 Logo

IELSG-26

This prospective multi-centre cohort study has been designed to investigate the diagnostic and prognostic utility of PET scan in primary mediastinal lymphoma.

MENOS4 Logo

MENOS4

A multicentre randomised controlled trial of a breast care nurse delivered cognitive behavioural therapy (CBT) intervention to reduce the impact of hot flushes in women with breast cancer.

Cancer Trials Ireland logo

Neo-AEGIS

Neoadjuvant and adjuvant chemotherapy (Investigator’s choice Modified MAGIC or FLOT regimen) vs. neoadjuvant chemoradiation (CROSS protocol) in adenocarcinoma of the oesophagus and oesophago-gastric junction

New EPOC logo

New EPOC

An open-label randomised trial, comparing OxMdG / IrMdG chemotherapy versus OxMdG / IrMdG chemotherapy plus Cetuximab.

PCV 13 in ALL Logo

PCV 13 in ALL

Investigating the clinical use of 13-valent pneumococcal conjugate vaccine (PCV13, Prevenar-13) in childhood Acute Lymphoblastic Leukaemia.

ProCAID logo

ProCAID

An open label phase I/randomised, double blind phase II study in metastatic castration resistant Prostate Cancer of AZD5363 In combination with Docetaxel and prednisolone chemotherapy.

SABRE1

SABRE1

A randomised feasibility study of brachytherapy and surgery in good risk prostate cancer.

SAFA logo

SAFA

A pragmatic multicentre double-blind randomised superiority trial to investigate the clinical and cost-effectiveness of spironolactone for moderate or severe persistent acne in women.

SAKK Logo

SAKK 08/11

A phase III trial investigating Orteronel maintenance therapy in patients with metastatic castration resistant prostate cancer and non-progressive disease after first-line docetaxel therapy.

SCHRIFT Logo

SCHRIFT

Short Chemo RadioImmunotherapy in Follicular Lymphoma Trial of 90Y Ibritumomab tiuxetan (Zevalin) as therapy for first and second relapse in Follicular Lymphoma.

SOMOSA LOGO

SoMOSA

Study of mechanisms of action of omalizumab in severe asthma.

SPIRE logo

SPIRE

A phase Ib/randomised IIa open label clinical trial combining SGI-110 with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer.

Logo for Sputnik

SPUtNIk

A prospective, observational study to assess the accuracy and cost effectiveness of dynamic contrast enhanced computed tomography in the characterisation of Solitary Pulmonary Nodules.

STOPAH Logo

STOPAH

STeroids or Pentoxifylline for Alcoholic Hepatitis.

Trans EPOC Logo

Trans EPOC

Investigating the molecular predictors of response in metastatic colorectal cancer.

WIN Logo

WIN

WT1 Immunity via DNA fusion Gene Vaccination in Haematological Malignancies by intramuscular injection followed by intramuscular electroporation.

Privacy Settings